
Results 1 - 20 of 333 in Kyphon
For the fifth straight year, Memphis-based Medtronic Spine employees are spending the month of June volunteering at more than a dozen locations in the area. Comment?
Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone...
w/Photo
Yale University researchers this week released the findings of two independent studies of Medtronic's Infuse bone graft products. Comment?
Medtronic slips after Infuse reviews detailed Shares of Medtronic...
Shares of Medtronic Inc. slipped Tuesday, a day after the medical device maker announced findings from independent reviews of studies of its Infuse bone graft THE SPARK: The Minneapolis company said the reviews, conducted through Yale University, concluded that clinical success rates with its Infuse product were equivalent to more traditional bone ... (more) Comment?
Medtronic's Infuse No Better Than Bone Graft With More Risk
Medtronic Inc.'s Infuse, designed to help bones heal after spinal surgery, works no better than a graft and carries side effects including an increased risk of cancer, two independent reviews found. Comment?
Medtronic Slips After Infuse Reviews Detailed
Shares of Medtronic Inc . slipped Tuesday, a day after the medical device maker announced findings from independent reviews of studies of its Infuse bone graft THE SPARK: The Minneapolis company with a presence in Memphis said the reviews, conducted through Yale University, concluded that clinical success rates with its Infuse product were ... (more) Comment?
First-of-Its-Kind Independent Review of INFUSE Bone Graft Coordinated by Yale University is Complete
June 17, 2013 - Medtronic, Inc. [NYSE: MDT] acknowledged today the publication of the findings from Yale University's third-party, independent review of INFUSEA Bone Graft, a proprietary formulation of recombinant human bone morphogenetic protein-2 that was approved by the U.S. Food and Drug Administration in 2002 for use in anterior lumbar ... (more) Comment?
One of my recent purchases for my Covestor Healthcare Model is Medtronic, Inc. . Comment?
The Changing Structure of Industry-Sponsored Clinical Research:...
Disclaimer: The author is an employee of Medtronic and serves as a member of the Board of Governors for the Patient Centered Outcomes Research Institute. Comment?
Medtronic's Infuse No Better Than Bone Graft With More Risk, Study Finds
Medtronic Inc. 's Infuse, designed to help bones heal after spinal surgery, works no better than a graft and carries side effects including an increased risk of cancer, two independent reviews found. Comment?
First-of-Its-Kind Independent Review of INFUSEA Bone Graft...
INFUSE Bone Graft Remains Important Treatment Option MINNEAPOLIS - June 17, 2013 - Medtronic, Inc. [NYSE: MDT] acknowledged today the publication of the findings from Yale University's third-party, independent review of INFUSE Bone Graft, a proprietary formulation of recombinant human bone morphogenetic protein-2 that was approved by the U.S. Food ... (more) Comment?
Medtronic Aortic Valves Don't Infringe Edwards German Patent
Medtronic Inc.'s aortic valve, inserted into the heart via a catheter, doesn't violate Edwards Lifesciences Inc.'s Cribier patent, the German District Court of Mannheim ruled. Comment?
Medtronic Aortic Valves Don't Infringe Edwards Patent in Germany
Medtronic Inc.'s aortic valve, inserted into the heart via a catheter, doesn't violate Edwards Lifesciences Inc.'s Cribier patent, the German District Court of Mannheim ruled. Comment?
Medtronic Unveils Baseline Data Of Extreme Risk Patients Enrolled In CoreValveA U.S. Pivotal Trial
Study Presents Comprehensive Dataset of Patient Characteristics Collected on Extreme Risk TAVR Patients VANCOUVER - June 14, 2013 - Medtronic, Inc. today presented baseline characteristics of patients enrolled in the Extreme Risk Study of the Medtronic CoreValve U.S. Pivotal Trial at the Transcatheter Valve Therapies conference. Comment?
Facebook Inc (FB), Edwards Lifesciences Corp (EW): Reasons to Buy These Three Stocks
w/Photo
It has been a tough year for Edwards Lifesciences Corp . The stock has declined 24% in 2013 alone due to disappointing sales. Comment?
Medtronic Stock Sees Short Interest Decline 18%
w/Photo
The most recent short interest data has been released by the NASDAQ for the 05/31/2013 settlement date, which shows a 2,351,638 share decrease in total short interest for Medtronic short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it ... (more) Comment?
FDA to medical-device makers: Prepare for hackers
The Food and Drug Administration wants med-tech companies such as Medtronic to ensure their devices can withstand cybersecurity threats. Comment?
Medtronic Announces CE Mark of ReDuX Plier Instrument
Medtronic, Inc. announced today the CE Mark and the European launch of the ReDuX Plier, a new instrument specially designed for use during osteotomies. Comment?
Medtronic Announces CE Mark of Its ReDuX(TM) Plier Instrument, an...
Novel Disruptive Instrument for Controlled and Progressive Restoration of the Sagittal Imbalance in Patient with Spinal Deformity NICE, France - June 13, 2013 - Medtronic, Inc. announced today the CE Mark and the European launch of the ReDuX Plier, a new instrument specially designed for use during osteotomies. Comment?
Providence Medical names vice president of sales
... president, sales for S-I BONE, Inc. Kevin worked closely with Providence's management in integrating St. Francis with Kyphon, and later with Medtronic, following its purchase of Kyphon. "I'm excited for Kevin to lead our US product launches and grow ... Comment?
Edwards Lifesciences Corp (EW): Is This Fallen Angel Still a Good Growth Play?
w/Photo
Healthcare stocks resemble tech stocks, in that both are eye candy to growth investors, show volatility over business cycles and thus have less appeal to value investors. Comment?